{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:25:23Z","timestamp":1788362723625,"version":"build-2803163510"},"reference-count":132,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FCT\/MCTES","award":["UIDB\/00511\/2020"],"award-info":[{"award-number":["UIDB\/00511\/2020"]}]},{"name":"FCT\/MCTES","award":["UIDP\/00511\/2020"],"award-info":[{"award-number":["UIDP\/00511\/2020"]}]},{"name":"FCT\/MCTES","award":["LA\/P\/0045\/2020"],"award-info":[{"award-number":["LA\/P\/0045\/2020"]}]},{"name":"Foundation for Science and Technology","award":["M-ERA-NET3\/0001\/2021"],"award-info":[{"award-number":["M-ERA-NET3\/0001\/2021"]}]},{"award":["M-ERA-NET3\/0001\/2021"],"award-info":[{"award-number":["M-ERA-NET3\/0001\/2021"]}],"id":[{"id":"https:\/\/ror.org\/053528t47","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Project Nano4Glio","award":["958174"],"award-info":[{"award-number":["958174"]}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["NORTE2030-FEDER-02696100"],"award-info":[{"award-number":["NORTE2030-FEDER-02696100"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"award":["NORTE2030-FEDER-02696100"],"award-info":[{"award-number":["NORTE2030-FEDER-02696100"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"publisher"}]},{"name":"FCT","award":["CEEC-IND\/01741\/2021"],"award-info":[{"award-number":["CEEC-IND\/01741\/2021"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a prevalent neurodegenerative disorder characterized by progressive dementia, constituting one of the leading causes of global mortality. Although the current treatments help attenuate the symptoms associated with AD, they are unable to stop the long-term progression of the disease, and consequently, no cure exists. One of the main reasons for the lack of cure and, therefore, one of the biggest challenges in its treatment, is the blood\u2013brain barrier (BBB). This protective barrier limits the entry of foreign substances, including drugs, into the central nervous system. Different types of engineered nanoparticles (NPs) have been demonstrated to be able to penetrate this barrier and serve as efficient drug delivery systems (DDS) into the brain, making them a promising solution for future therapeutic development. Therefore, the purpose of this paper is to provide valuable insights into challenges faced by DDS in treating AD, highlight the nanotechnology-based approach, and discuss the advances in strategies being employed to enhance the crossing of NPs through the BBB. Furthermore, some up-to-date NP systems are presented, along with the latest therapeutic agents targeting AD, and finally, it underscores innovative approaches under investigation. Ultimately, the barriers hindering the clinical translation of NP-based strategies into human patients are discussed.<\/jats:p>","DOI":"10.3390\/ph19050685","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:34:42Z","timestamp":1777458882000},"page":"685","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advances in Strategies to Transport Nanoparticles Across the Blood\u2013Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7627-8627","authenticated-orcid":false,"given":"Rafael","family":"Silva","sequence":"first","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2101-5322","authenticated-orcid":false,"given":"Joana","family":"Monteiro","sequence":"additional","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2428-7520","authenticated-orcid":false,"given":"Maria Jo\u00e3o","family":"Ramalho","sequence":"additional","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6918-8775","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Andrade","sequence":"additional","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9841-3967","authenticated-orcid":false,"given":"Joana A.","family":"Loureiro","sequence":"additional","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"Department of Mechanical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-3432","authenticated-orcid":false,"given":"Maria Carmo","family":"Pereira","sequence":"additional","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pathol.2024.10.006","article-title":"Current concepts and molecular pathology of neurodegenerative diseases","volume":"57","author":"Forrest","year":"2025","journal-title":"Pathology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lamptey, R.N.L., Chaulagain, B., Trivedi, R., Gothwal, A., Layek, B., and Singh, J. (2022). A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031851"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1586\/ern.11.155","article-title":"Distinguishing Alzheimer\u2019s disease from other major forms of dementia","volume":"11","author":"Karantzoulis","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: Structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Nunes, D., Loureiro, J.A., and Pereira, M.C. (2022). Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer\u2019s Drugs. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14112296"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1734-1140(12)70901-5","article-title":"Nanoparticles as drug delivery systems","volume":"64","author":"Wilczewska","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6564585","DOI":"10.1155\/2021\/6564585","article-title":"Blood-Brain Barrier Overview: Structural and Functional Correlation","volume":"2021","author":"Alahmari","year":"2021","journal-title":"Neural Plast."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-0716-3429-5_16","article-title":"Measurement of Transendothelial Electrical Resistance in Blood-Brain Barrier Endothelial Cells","volume":"2711","author":"Waithe","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jiao, Y., Yang, L., Wang, R., Song, G., Fu, J., Wang, J., Gao, N., and Wang, H. (2024). Drug Delivery Across the Blood\u2013Brain Barrier: A New Strategy for the Treatment of Neurological Diseases. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16121611"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresbull.2022.09.017","article-title":"The barrier and interface mechanisms of the brain barrier, and brain drug delivery","volume":"190","author":"Zhang","year":"2022","journal-title":"Brain Res. Bull."},{"key":"ref_13","unstructured":"Dotiwala, A.K., McCausland, C., and Samra, N.S. (2025, October 01). Anatomy, Head and Neck: Blood Brain Barrier, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519556\/."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Poudel, P., and Park, S. (2022). Recent Advances in the Treatment of Alzheimer\u2019s Disease Using Nanoparticle-Based Drug Delivery Systems. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14040835"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2147\/IJN.S439181","article-title":"Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations","volume":"19","author":"Koo","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Pardridge, W.M. (2022). A Historical Review of Brain Drug Delivery. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14061283"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: Physiology and strategies for drug delivery","volume":"165\u2013166","author":"Pandit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ding, L., Kshirsagar, P., Agrawal, P., and Murry, D.J. (2025). Crossing the Blood\u2013Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17060706"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107554","DOI":"10.1016\/j.pharmthera.2020.107554","article-title":"Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders","volume":"213","author":"Barbosa","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"166967","DOI":"10.1016\/j.bbadis.2023.166967","article-title":"Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer\u2019s disease and strategies for treatment","volume":"1870","author":"Chaves","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Basis Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00232-025-00341-8","article-title":"Role of Ion Channels in Alzheimer\u2019s Disease Pathophysiology","volume":"258","author":"Bhoi","year":"2025","journal-title":"J. Membr. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/cns.13893","article-title":"The role of Na+-K+-ATPase in the epileptic brain","volume":"28","author":"Sun","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s13346-019-00694-3","article-title":"Nanotechnology to improve the Alzheimer\u2019s disease therapy with natural compounds","volume":"10","author":"Ramalho","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2217\/nnm-2018-0139","article-title":"Nanoparticle crossing of blood-brain barrier: A road to new therapeutic approaches to central nervous system diseases","volume":"13","year":"2018","journal-title":"Nanomedicine"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Mudalige, T., Qu, H., Van Haute, D., Ansar, S.M., Paredes, A., and Ingle, T. (2018). Chapter 11\u2014Characterization of Nanomaterials: Tools and Challenges. Nanomaterials for Food Applications, Elsevier. [1st ed.].","DOI":"10.1016\/B978-0-12-814130-4.00011-7"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Carvalho, P.M., Fel\u00edcio, M.R., Santos, N.C., Gon\u00e7alves, S., and Domingues, M.M. (2018). Application of Light Scattering Techniques to Nanoparticle Characterization and Development. Front. Chem., 6.","DOI":"10.3389\/fchem.2018.00237"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Villanueva-Flores, F., Parra-Gonz\u00e1lez, M., Peralta-Cuevas, E., Gutierrez-Onofre, A.J., Garcia-Atutxa, I., and Villanueva-Flores, F. (2025). Cracking the Blood\u2013Brain Barrier Code: Rational Nanomaterial Design for Next-Generation Neurological Therapies. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17091169"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"122167","DOI":"10.1016\/j.ijpharm.2022.122167","article-title":"Transferrin-functionalized liposomes loaded with vitamin VB12 for Alzheimer\u2019s disease therapy","volume":"626","author":"Andrade","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Del Amo, L., Cano, A., Ettcheto, M., Souto, E.B., Espina, M., Camins, A., Garc\u00eda, M.L., and S\u00e1nchez-L\u00f3pez, E. (2021). Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer\u2019s Disease. Appl. Sci., 11.","DOI":"10.3390\/app11094305"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Sarker, S.D., and Nahar, L. (2022). Characterization of nanoparticles. Advances in Nanotechnology-Based Drug Delivery Systems, Elsevier.","DOI":"10.1016\/B978-0-323-88450-1.00011-9"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.1216893110","article-title":"Particle shape enhances specificity of antibody-displaying nanoparticles","volume":"110","author":"Barua","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"103080","DOI":"10.1016\/j.tice.2025.103080","article-title":"Shape and surface modification dependent cellular interactions of gold nanoparticles in a 3D blood-brain-barrier supported neurospheroid model","volume":"97","author":"Tomak","year":"2025","journal-title":"Tissue Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1021\/acsbiomaterials.0c00743","article-title":"Effect of Nanoparticle Composition, Size, Shape, and Stiffness on Penetration Across the Blood\u2013Brain Barrier","volume":"6","author":"TBrown","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery","volume":"2","author":"Geng","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1039\/D5PM00179J","article-title":"Advancements in nano-based drug delivery systems for therapeutics: A comprehensive review","volume":"3","author":"John","year":"2026","journal-title":"RSC Pharm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tifs.2019.01.013","article-title":"Liposomal delivery of natural product: A promising approach in health research","volume":"85","author":"Shishir","year":"2019","journal-title":"Trends Food Sci. Technol."},{"key":"ref_38","unstructured":"(2026, April 17). Polymer Nanoparticles\u2014An Overview|ScienceDirect Topics. Available online: https:\/\/www.sciencedirect.com\/topics\/materials-science\/polymer-nanoparticles."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2217\/nnm-2019-0443","article-title":"Current Advances in the Development of Novel Polymeric Nanoparticles for the Treatment of Neurodegenerative Diseases","volume":"15","author":"Cano","year":"2020","journal-title":"Nanomedicine"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chen, Y., He, Y., Han, J., Wei, W., and Chen, F. (2023). Blood-brain barrier dysfunction and Alzheimer\u2019s disease: Associations, pathogenic mechanisms, and therapeutic potential. Front. Aging Neurosci., 15.","DOI":"10.3389\/fnagi.2023.1258640"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood-brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1134\/S1062359014030042","article-title":"Bioaccumulation of silver and gold nanoparticles in organs and tissues of rats studied by neutron activation analysis","volume":"41","author":"Buzulukov","year":"2014","journal-title":"Biol. Bull."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hersh, A.M., Alomari, S., and Tyler, B.M. (2022). Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology. Int. J. Mol. Sci., 2022.","DOI":"10.3390\/ijms23084153"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12951-018-0356-z","article-title":"Memantine loaded PLGA PEGylated nanoparticles for Alzheimer\u2019s disease: In vitro and in vivo characterization","volume":"16","author":"Ettcheto","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102048","DOI":"10.1016\/j.jsps.2024.102048","article-title":"Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer\u2019s disease","volume":"32","author":"Imam","year":"2024","journal-title":"Saudi Pharm. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"102214","DOI":"10.1016\/j.jddst.2020.102214","article-title":"Brain targeted Polysorbate-80 coated PLGA thymoquinone nanoparticles for the treatment of Alzheimer\u2019s disease, with biomechanistic insights","volume":"61","author":"Yusuf","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"101406","DOI":"10.1016\/j.nanoso.2024.101406","article-title":"Enhanced delivery of rivastigmine for Alzheimer\u2019s disease: Convolvulus pluricaulis lipid hybrid nanoparticles","volume":"40","author":"Garg","year":"2024","journal-title":"Nano-Struct. Nano-Objects"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"122121","DOI":"10.1016\/j.carbpol.2024.122121","article-title":"Polymeric nanoparticles decorated with fragmented chitosan as modulation systems for neuronal drug uptake","volume":"336","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.2147\/IJN.S239608","article-title":"Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer\u2019s Disease-Related Pathology in APP\/PS-1 Mice","volume":"15","author":"Kong","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.colsurfb.2016.04.041","article-title":"Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and antitransferrin receptor antibodies for Alzheimer\u2019s disease treatment","volume":"145","author":"Loureiro","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1080\/10717544.2018.1461955","article-title":"Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer\u2019s disease","volume":"25","author":"Fan","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2217\/nnm-2017-0022","article-title":"The effect of nanoparticle size on the ability to cross the blood-brain barrier: An in vivo study","volume":"12","author":"Betzer","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"121690","DOI":"10.1016\/j.biomaterials.2022.121690","article-title":"Blood-brain barrier Permeable nanoparticles for Alzheimer\u2019s disease treatment by selective mitophagy of microglia","volume":"288","author":"Zhong","year":"2022","journal-title":"Biomaterials"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1080\/09205063.2025.2486863","article-title":"Folic acid-conjugated amphiphilic copolymers for the enhanced delivery of donepezil: Synthesis, characterization and blood-brain barrier permeability in a co-culture model","volume":"36","author":"Fritzen","year":"2025","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"106680","DOI":"10.1016\/j.jddst.2025.106680","article-title":"Regional brain distribution of PLGA nanoparticles functionalized with glutathione or phenylalanine dipeptide","volume":"105","author":"Alonso","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_56","first-page":"3547","article-title":"A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants","volume":"7","author":"Xu","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e2502595","DOI":"10.1002\/adhm.202502595","article-title":"KLVFF-Guided Molecular Scissors: A Trojan Horse Strategy for Precision Photodynamic Dissolution of A\u03b2 Aggregates","volume":"14","author":"Ye","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"ref_58","first-page":"529","article-title":"Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer\u2019s disease mice","volume":"6","author":"Han","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbi.2024.05.006","article-title":"Microgliatargeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behaviour in a mouse model of Alzheimer\u2019s disease","volume":"119","author":"Badr","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"44447","DOI":"10.1021\/acsami.0c11064","article-title":"Development of a Tau-Targeted Drug Delivery System Using a Multifunctional Nanoscale Metal\u2013Organic Framework for Alzheimer\u2019s Disease Therapy","volume":"12","author":"Zhao","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bk-2022-1418.ch001","article-title":"Functionalization of Nanomaterials: Synthesis and Characterization","volume":"1418","author":"Rizvi","year":"2022","journal-title":"ACS Symp. Ser."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Makharadze, D., del Valle, L.J., Katsarava, R., and Puiggal\u00ed, J. (2025). The Art of PEGylation: From Simple Polymer to Sophisticated Drug Delivery System. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202502.0191.v1"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Pad\u00edn-Gonz\u00e1lez, E., Lancaster, P., Bottini, M., Gasco, P., Tran, L., Fadeel, B., Wilkins, T., and Monopoli, M.P. (2022). Understanding the Role and Impact of Poly (Ethylene Glycol) (PEG) on Nanoparticle Formulation: Implications for COVID-19 Vaccines. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.882363"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12943-025-02410-x","article-title":"PEGylated PLGA nanoparticles: Unlocking advanced strategies for cancer therapy","volume":"24","author":"Kesharwani","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijbiomac.2022.03.203","article-title":"Functionalized nanoparticles for brain targeted BDNF gene therapy to rescue Alzheimer\u2019s disease pathology in transgenic mouse model","volume":"208","author":"Arora","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e2306675","DOI":"10.1002\/advs.202306675","article-title":"Hybrid Membrane-Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer\u2019s Disease","volume":"11","author":"Lin","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13195-024-01470-3","article-title":"Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer\u2019s disease mouse model","volume":"16","author":"Henningfield","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13195-025-01840-5","article-title":"Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer\u2019s disease in a mouse model","volume":"17","author":"Pan","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"212827","DOI":"10.1016\/j.bioadv.2022.212827","article-title":"Transferrin decorated-nanostructured lipid carriers (NLCs) are a promising delivery system for rapamycin in Alzheimer\u2019s disease: An in vivo study","volume":"137","author":"Khonsari","year":"2022","journal-title":"Biomater. Adv."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-025-02426-1","article-title":"Rapid amyloid-\u03b2 clearance and cognitive recovery through multivalent modulation of blood\u2013brain barrier transport","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_71","first-page":"114300","article-title":"Multifunctional mesoporous nanoselenium delivery of metformin breaks the vicious cycle of neuroinflammation and ROS, promotes microglia regulation and alleviates Alzheimer\u2019s disease","volume":"245","author":"Zhang","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12951-024-02543-z","article-title":"A\u03b242 and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer\u2019s disease","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1038\/s41467-020-18525-2","article-title":"Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"11","author":"Hou","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.2147\/IJN.S434873","article-title":"Functionalized Cerium Dioxide Nanoparticles with Antioxidative Neuroprotection for Alzheimer\u2019s Disease","volume":"18","author":"Hu","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Santiago, J.A., and Potashkin, J.A. (2021). The Impact of Disease Comorbidities in Alzheimer\u2019s Disease. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.631770"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Jimenez, M.T.B., Rivas-Garc\u00eda, L., S\u00e1nchez-Gonz\u00e1lez, C., Grosso, G., Lipari, V., Vera-Ram\u00edrez, L., Battino, M., Giampieri, F., Quiles, J.L., and Forbes-Hern\u00e1ndez, T.Y. (2025). Natural Products in Alzheimer\u2019s Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262110631"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Andrade, S., Ramalho, M.J., Loureiro, J.A., and Pereira, M.D.C. (2019). Natural Compounds for Alzheimer\u2019s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092313"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","article-title":"Functionalized Nanomaterials Capable of Crossing the Blood\u2013Brain Barrier","volume":"18","author":"Zha","year":"2024","journal-title":"ACS Nano"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e37533","DOI":"10.1016\/j.heliyon.2024.e37533","article-title":"A comprehensive review of advanced focused ultrasound (FUS) microbubbles-mediated treatment of Alzheimer\u2019s disease","volume":"10","author":"Rouhi","year":"2024","journal-title":"Heliyon"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"114539","DOI":"10.1016\/j.addr.2022.114539","article-title":"Ultrasound-mediated blood\u2013brain barrier opening: An effective drug delivery system for theranostics of brain diseases","volume":"190","author":"Wang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11060-024-04795-z","article-title":"Focused ultrasound-mediated enhancement of blood-brain barrier permeability for brain tumor treatment: A systematic review of clinical trials","volume":"170","author":"Zhu","year":"2024","journal-title":"J. Neurooncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2014.06.031","article-title":"Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood \u2212 brain barrier using MRI-guided focused ultrasound","volume":"189","author":"Nance","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","article-title":"Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain","volume":"348","author":"Ogawa","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"18220","DOI":"10.1038\/s41598-020-75253-9","article-title":"Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood\u2013brain barrier opening","volume":"10","author":"Ohta","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1039\/C9NR09713A","article-title":"Microbubbles in combination with focused ultrasound for the delivery of quercetin-modified sulfur nanoparticles through the blood brain barrier into the brain parenchyma and relief of endoplasmic reticulum stress to treat Alzheimer\u2019s disease","volume":"12","author":"Liu","year":"2020","journal-title":"Nanoscale"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Parvin, N., Joo, S.W., and Mandal, T.K. (2025). Biodegradable and Stimuli-Responsive Nanomaterials for Targeted Drug Delivery in Autoimmune Diseases. J. Funct. Biomater., 16.","DOI":"10.3390\/jfb16010024"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"11015","DOI":"10.2147\/IJN.S549893","article-title":"Nanotechnology for Neurodegenerative Diseases: Recent Progress in Brain-Targeted Delivery, Stimuli-Responsive Platforms, and Organelle-Specific Therapeutics","volume":"20","author":"Gao","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"122588","DOI":"10.1016\/j.ijpharm.2023.122588","article-title":"Nose-to-brain delivery of galantamine loaded nanospray dried polyacrylic acid\/taurodeoxycholate mixed matrix as a protective therapy in lipopolysaccharide-induced Alzheimer\u2019s in mice model","volume":"632","author":"Elhabak","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"110096","DOI":"10.1016\/j.neuropharm.2024.110096","article-title":"Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer\u2019s disease","volume":"259","author":"Kamath","year":"2024","journal-title":"Neuropharmacology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2024.09.009","article-title":"Biofilm-camouflaged Prussian blue synergistic mitochondrial mass enhancement for Alzheimer\u2019s disease based on Cu2+ chelation and photothermal therapy","volume":"375","author":"Li","year":"2024","journal-title":"J. Control. Release"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.actbio.2016.09.010","article-title":"Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer\u2019s disease treatment","volume":"46","author":"Yang","year":"2016","journal-title":"Acta Biomater."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1039\/D1TB01290H","article-title":"A diselenide bond-containing ROS-responsive ruthenium nanoplatform delivers nerve growth factor for Alzheimer\u2019s disease management by repairing and promoting neuron regeneration","volume":"9","author":"Yuan","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2100746","DOI":"10.1002\/adma.202100746","article-title":"Biomimetic Dendrimer-Peptide Conjugates for Early Multi-Target Therapy of Alzheimer\u2019s Disease by Inflammatory Microenvironment Modulation","volume":"33","author":"Liu","year":"2021","journal-title":"Adv. Mater."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.2147\/IJN.S215404","article-title":"Targeted acetylcholinesterase-responsive drug carriers with long duration of drug action and reduced hepatotoxicity","volume":"14","author":"Lin","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"106803","DOI":"10.1016\/j.jddst.2025.106803","article-title":"Cationic lipid based nanoparticles-formulated artesunate as a neurotherapeutic agent in Alzheimer\u2019s disease: Targeting inflammasome activation and pyroptosis pathway","volume":"107","author":"Attia","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1039\/D0TB01863E","article-title":"Inhibition and disaggregation of amyloid \u03b2 protein fibrils through conjugated polymer\u2013core thermoresponsive micelles","volume":"8","author":"Geng","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e1801852","DOI":"10.1002\/smll.201801852","article-title":"Near-Infrared Switchable Fullerene-Based Synergy Therapy for Alzheimer\u2019s Disease","volume":"14","author":"Du","year":"2018","journal-title":"Small"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Muolokwu, C.E., Chaulagain, B., Gothwal, A., Mahanta, A.K., Tagoe, B., Lamsal, B., and Singh, J. (2024). Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer\u2019s disease. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1405423"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","article-title":"Nanodelivery of nucleic acids","volume":"2","author":"Mendes","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Mendes, L.P., Pan, J., and Torchilin, V.P. (2017). Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy. Molecules, 22.","DOI":"10.3390\/molecules22091401"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/acs.molpharmaceut.0c00461","article-title":"Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood\u2013Brain Barrier for Effective Treatment of Alzheimer\u2019s Disease","volume":"18","author":"Arora","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Lee, D., Shen, A.M., Shah, M., Garbuzenko, O.B., and Minko, T. (2024). In Vivo Evaluation of Nose-to-Brain Delivery of Liposomal Donepezil, Memantine, and BACE-1 siRNA for Alzheimer\u2019s Disease Therapy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910357"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"143152","DOI":"10.1016\/j.cej.2023.143152","article-title":"Engineering brain-derived neurotrophic factor mRNA delivery for the treatment of Alzheimer\u2019s disease","volume":"466","author":"Li","year":"2023","journal-title":"Chem. Eng. J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e39607","DOI":"10.1016\/j.heliyon.2024.e39607","article-title":"Brain-targeting liposome-based APOE2 gene delivery exacerbates soluble amyloid-\u03b2 accumulation in AppNL\u2212G-F mice","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1389201020666190204141046","article-title":"In vivo Evaluation and Alzheimer\u2019s Disease Treatment Outcome of siRNA Loaded Dual Targeting Drug Delivery System","volume":"20","author":"Zhang","year":"2019","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"eabc7031","DOI":"10.1126\/sciadv.abc7031","article-title":"Blood-brain barrierpenetrating siRNA nanomedicine for Alzheimer\u2019s disease therapy","volume":"6","author":"Zhou","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/10717544.2020.1775724","article-title":"Multifunctional magnetite nanoparticles to enable delivery of siRNA for the potential treatment of Alzheimer\u2019s","volume":"27","author":"Garcia","year":"2020","journal-title":"Drug Deliv."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","article-title":"In vivo neuronal gene editing via CRISPR\u2013Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer\u2019s disease","volume":"22","author":"Park","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e2208018","DOI":"10.1002\/adma.202208018","article-title":"Overcoming the Blood-Brain Barrier for Gene Therapy via Systemic Administration of GSH-Responsive Silica Nanocapsules","volume":"35","author":"Wang","year":"2023","journal-title":"Adv. Mater."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Carrillo-Jimenez, A., Puigdell\u00edvol, M., Vilalta, A., Venero, J.L., Brown, G.C., StGeorge-Hyslop, P., and Burguillos, M.A. (2018). Effective Knockdown of Gene Expression in Primary Microglia with siRNA and Magnetic Nanoparticles Without Cell Death or Inflammation. Front. Cell. Neurosci., 12.","DOI":"10.3389\/fncel.2018.00313"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/JIR.S466821","article-title":"Unveiling the Complex Role of Exosomes in Alzheimer\u2019s Disease","volume":"17","author":"Sun","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"100032","DOI":"10.1016\/j.vesic.2023.100032","article-title":"Exosome as drug delivery system: Current advancements","volume":"3","author":"Sharma","year":"2024","journal-title":"Extracell. Vesicle"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Koh, H.B., Kim, H.J., Kang, S.W., and Yoo, T.H. (2023). Exosome-Based Drug Delivery: Translation from Bench to Clinic. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15082042"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"112365","DOI":"10.1016\/j.msec.2021.112365","article-title":"Biomimetic silibinin-loaded macrophage-derived exosomes induce dual inhibition of A\u03b2 aggregation and astrocyte activation to alleviate cognitive impairment in a model of Alzheimer\u2019s disease","volume":"129","author":"Huo","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/10717544.2020.1762262","article-title":"Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles","volume":"27","author":"Qi","year":"2020","journal-title":"Drug Deliv."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1039\/C9NR01255A","article-title":"Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT\/GSK-3\u03b2 pathway","volume":"11","author":"Wang","year":"2019","journal-title":"Nanoscale"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1039\/D3NA00180F","article-title":"Machine learning assisted nanomedicine using magnetic nanoparticles for central nervous system diseases","volume":"5","author":"Tomitaka","year":"2023","journal-title":"Nanoscale Adv."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1166\/jnn.2021.19062","article-title":"Recent Advances in the Development of Magnetic Nanoparticles for Biomedical Applications","volume":"21","author":"Larumbe","year":"2021","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"100163","DOI":"10.1016\/j.apsadv.2021.100163","article-title":"Magnetic nanoparticles in biomedical applications: A review","volume":"6","author":"Miyazaki","year":"2021","journal-title":"Appl. Surf. Sci. Adv."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Editors, A., Tombuloglu, H., Baykal, A., Carniato, F., Vargas-Ortiz, J.R., Gonzalez, C., and Esquivel, K. (2022). Magnetic Iron Nanoparticles: Synthesis, Surface Enhancements, and Biological Challenges. Processes, 10.","DOI":"10.3390\/pr10112282"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"055101","DOI":"10.1088\/0957-4484\/25\/5\/055101","article-title":"Enhanced blood\u2013brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation","volume":"25","author":"Ding","year":"2014","journal-title":"Nanotechnology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"17589","DOI":"10.1039\/D2NR02210A","article-title":"Transmigration of magnetite nanoparticles across the blood\u2013brain barrier in a rodent model: Influence of external and alternating magnetic fields","volume":"14","author":"Gupta","year":"2022","journal-title":"Nanoscale"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/acs.nanolett.2c03682","article-title":"Iron Oxide Nanoparticle-Incorporated Mesenchymal Stem Cells for Alzheimer\u2019s Disease Treatment","volume":"23","author":"Jung","year":"2023","journal-title":"Nano Lett."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1126\/sciadv.adl2991","article-title":"D-peptide- magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer\u2019s disease","volume":"10","author":"Hou","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1039\/C7NR00772H","article-title":"Osmotin-loaded magnetic nanoparticles with electromagnetic guidance for the treatment of Alzheimer\u2019s disease","volume":"9","author":"Amin","year":"2017","journal-title":"Nanoscale"},{"key":"ref_126","first-page":"281","article-title":"Donepezil-loaded PLGA-b-PEG Nanoparticles Enhance the Learning and Memory Function of Beta-Amyloid Rat Model of Alzheimer\u2019s Disease","volume":"59","author":"Mutluay","year":"2022","journal-title":"Arch. Neuropsychiatry"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"114426","DOI":"10.1016\/j.jconrel.2025.114426","article-title":"Clinical translation of nanomedicines for brain diseases: Current challenges and future directions","volume":"389","author":"Wang","year":"2026","journal-title":"J. Control. Release"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/1061186X.2024.2316785","article-title":"Nanoparticles toxicity: An overview of its mechanism and plausible mitigation strategies","volume":"32","author":"Sharma","year":"2024","journal-title":"J. Drug Target."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Wang, K., Yang, R., Li, J., Wang, H., Wan, L., and He, J. (2025). Nanocarrier-based targeted drug delivery for Alzheimer\u2019s disease: Addressing neuroinflammation and enhancing clinical translation. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1591438"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"100007","DOI":"10.1016\/j.nbe.2025.100007","article-title":"Research application of immunomodulatory nanomaterials in Alzheimer\u2019s disease vaccine development","volume":"18","author":"Guo","year":"2026","journal-title":"Nano Biomed. Eng."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3233\/JAD-240058","article-title":"Addressing the Discrepancies Between Animal Models and Human Alzheimer\u2019s Disease Pathology: Implications for Translational Research","volume":"98","author":"Polis","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12951-024-02720-0","article-title":"Brain-on-a-chip: An emerging platform for studying the nanotechnology-biology interface for neurodegenerative disorders","volume":"22","author":"Rodrigues","year":"2024","journal-title":"J. Nanobiotechnol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/5\/685\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:12:18Z","timestamp":1777522338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/5\/685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":132,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ph19050685"],"URL":"https:\/\/doi.org\/10.3390\/ph19050685","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}